Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2024-04-09 | Mark J. Enyedy has served on our Board since December 2023. Mr. Enyedy served as the President and Chief Executive Officer of ImmunoGen, Inc., a public biotechnology company, from May 2016 until February 2024, when ImmunoGen, Inc. was acquired by AbbVie Inc. ... 2023 Independent Director Compensation ... Mark J. Enyedy — Fees Earned or Paid in Cash, 213,378 Stock Awards, 213,378 Total. |
| 2025-04-08 | Mark J. Enyedy has served on our Board since December 2023. Mr. Enyedy served as the President and CEO of ImmunoGen, Inc. He holds a B.S. from Northeastern University and a J.D. from Harvard Law School. 2024 Non-Employee Director Compensation: Mark J. Enyedy received total compensation of $461,170. |
Data sourced from SEC filings. Last updated: 2026-03-05